PlainRecalls

Novel Laboratories, Inc. d.b.a Lupin

Compiled from official public sources by the publisher.

1 recalls on record · Latest: Aug 25, 2021

Subscribe to new Novel Laboratories, Inc. d.… recalls (RSS)

Agency notice ledger

Federal filing book Novel Laboratories, Inc. d.… SINGLE · SINGLE-AGENCY

#11,157 of 14,151 · 1 notices · 0.001% archive

  • BOOK 1 notices
  • RANK #11,157 of 14,151
  • SHARE 0.001% archive
  • AGENCY FDA Drug (1)
  • CAT drugs
  • CATS 1 category
  • LATEST Aug 25, 2021
  • PHOTO —

Novel Laboratories, Inc. d.b.a Lupin accounts for about 0.001% of the 104,423-notice archive on 1 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category →

How Novel Laboratories, Inc. d.… compares to 14,151 recalling firms

Novel Laboratories, Inc. d.b.a Lupin ranks 11,157th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Novel Laboratories, Inc. d.… vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

1 11157th of 14151 the lowest of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-14

FDA Drug Moderate Aug 25, 2021

GaviLyteTM - C PEG-3350 (240g) and Electrolytes for Oral Solution, USP with Flavor Pack Manufactured by Novel Laboratories, Inc. Somerset, NJ 08873, USA Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 NDC 43386-060-19

Frequently Asked Questions

How many federal recall notices name Novel Laboratories, Inc. d.…? ▼
PlainRecalls indexes 1 distinct federal recall events naming Novel Laboratories, Inc. d.b.a Lupin, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Novel Laboratories, Inc. d.… sit among other recalling firms? ▼
Novel Laboratories, Inc. d.b.a Lupin ranks #11,157 of 14,151 by distinct recall-event count among 14,151 firms in this archive (tied at the bottom of the notice-count distribution (no firm has fewer notices)). Rank tracks filing frequency, not product danger.
Which agency issues most of Novel Laboratories, Inc. d.…'s notices? ▼
FDA Drug accounts for 1 of this firm's 1 indexed notices.
What product category dominates Novel Laboratories, Inc. d.…'s filing book? ▼
Filings for Novel Laboratories, Inc. d.b.a Lupin span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Novel Laboratories, Inc. d.b.a Lupin: 1 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Novel Laboratories, Inc. d.b.a Lupin; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026